The emerging therapeutic target of dynamic and reversible N6-methyladenosine modification during cancer development

As a reversible and dynamic epigenetic modification, N6-methyladenosine (m6A) modification is ubiquitous in eukaryotic cells. m6A methylation is prevalent in almost all RNA metabolism processes that affect the fate of cells, including cancer development. As indicated by the available evidence, targe...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Shougeng, Chen, Sihong, Tang, Chengfang, Zhao, Yingxi, Cui, Wei, Jia, Lina, Wang, Lihui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548694/
https://www.ncbi.nlm.nih.gov/pubmed/36226062
http://dx.doi.org/10.3389/fonc.2022.970833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548694/
https://www.ncbi.nlm.nih.gov/pubmed/36226062
http://dx.doi.org/10.3389/fonc.2022.970833

Ejemplares similares